ROSUVASTAX DROSSAPHARM cpr pellic 10 mg 100 pce

7680696130040 CH-69613 C10AA07 07.12.0.

Active substances:

Rosuvastatinum

No images available

Details

Product number
6961302
CPT
-
Packaging group
100
Unit
Tablette(n)
Composition
Filmtablette: rosuvastatinum 10 mg ut rosuvastatinum calcicum 10.42 mg, cellulosum microcristallinum, lactosum monohydricum 97.97 mg, crospovidonum, hydroxypropylcellulosum, natrii hydrogenocarbonas corresp. natrium 0.14 mg, magnesii stearas, Überzug: lactosum monohydricum 1.156 mg, hypromellosum, E 171, triacetinum, E 172 (rubrum), pro compresso obducto.

Articles (1)

Rosuvastax-Drossapharm 10 mg, Filmtabletten
Filmtabletten
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/09/2026
Patient information leaflet
Français
22/09/2026
Patient information leaflet
Italien
22/09/2026
Professional SmPC
Allemand
22/09/2026
Professional SmPC
Français
22/09/2026
Professional SmPC
Italien
22/09/2026

Detailed composition

Substance Quantity Type Category
rosuvastatinum
10.0 MG Substance Wirkstoff (Principe actif)
rosuvastatinum calcicum
10.42 MG Substance WIZUS
cellulosum microcristallinum
- Substance HNIDK
lactosum monohydricum
97.97 MG Substance HBESI
crospovidonum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
natrii hydrogenocarbonas
- Substance HNIDK
natrium
0.14 MG Substance HBESI
magnesii stearas
- Substance HNIDK
lactosum monohydricum
1.156 MG Substance HBESI
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
triacetinum
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK

Reimbursement information

Public price
CHF 45.80
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2026

Authorization holder

Drossapharm AG

4051 Basel

Authorization information

Swissmedic authorization number
69613
Drug name
Rosuvastax-Drossapharm, Filmtabletten
Galenic form
FILM
ATC Code
C10AA07
Authorization status
Z
Dispensation category
B
First authorization
03/04/2025
Authorization expiration date
02/04/2030
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration. Vorbeugung kardiovaskulärer Ereignisse bei Erwachsenen mit normalem LDL-Cholesterin Spiegel und erhöhtem Risiko von atherosklerotischen kardiovaskulären Erkrankungen.

Packaging details

Description (FR)
ROSUVASTAX DROSSAPHARM cpr pellic 10 mg 100 pce
Description (DE)
ROSUVASTAX DROSSAPHARM Filmtabl 10 mg 100 Stk
Market launch
01/09/2026
Narcotic (BTM)
No

Original drug

Crestor, Filmtabletten
GTIN: 7680561390067
CHF 29.50
View original

Other packaging sizes

ROSUVASTAX DROSSAPHARM cpr pellic 5 mg 30 pce
30 TABL
GTIN: 7680696130019
View
ROSUVASTAX DROSSAPHARM cpr pellic 5 mg 100 pce
100 TABL
GTIN: 7680696130026
View
ROSUVASTAX DROSSAPHARM cpr pellic 10 mg 30 pce
30 TABL
GTIN: 7680696130033
View
ROSUVASTAX DROSSAPHARM cpr pellic 20 mg 30 pce
30 TABL
GTIN: 7680696130057
View
ROSUVASTAX DROSSAPHARM cpr pellic 20 mg 100 pce
100 TABL
GTIN: 7680696130064
View
Buy us a coffee Explore the data